Navigation Links
Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
Date:4/15/2008

Phase 1 or Phase 2 clinical trials may not necessarily be indicative of future clinical trial results; our ability to estimate accurately the amount of cash to be used to fund operations over the next 12 months, our ability to obtain future financing and fund the product development of our pipeline; the initiation, timing, design, enrollment and cost of clinical trials and preclinical studies; our ability to establish successful partnerships and collaborations with third parties; the regulatory approval process in the United States and other countries; and our future capital requirements. For further information about these risks and other factors that may affect the actual results achieved by Pharmacyclics, please see the company's reports as filed with the U.S. Securities and Exchange Commission from time to time, including but not limited to its annual report on Form 10-K for the period ended June 30, 2007 and its subsequently filed quarterly reports on Form 10-Q. Forward-looking statements contained in this announcement are made as of this date, and we undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Pharmacyclics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
2. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
3. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
4. NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection
5. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
6. MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics
7. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
8. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
9. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
10. New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women
11. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... -- InVivo Therapeutics Holdings Corp. (OTCQB: NVIV) based in ... cord injury (SCI) treatment with their novel Neuro-Spinal Scaffold. ... regrowth in the spinal cord area when cells are ... polymer, the scaffold ultimately breaks down to water and ... NVIV has recently attracted significant investor attention with the ...
(Date:10/22/2014)... , Oct. 22, 2014 WHEN: Wednesday, October ... complimentary registration available at: http://bit.ly/1yStiU9 ... Vidyasekar and Visionary Innovation Research Group Senior ... electricity, self-assembling materials, nanobots and flexible electronics ... will transform our lives in the coming ...
(Date:10/22/2014)... 22, 2014 Provectus Biopharmaceuticals, Inc. (NYSEMKT: PVCT) ... novel investigational drug for cancer, is designed for injection ... effects. Its oncology focus is on melanoma, breast cancer ... 2 trials of PV-10 as a therapy for metastatic ... atopic dermatitis and psoriasis. This summer, ...
Breaking Medicine Technology:InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
... 24, 2012 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: ... manufacturer and marketer of orthopedic implants in China, today announced ... First Quarter 2012 Highlights , ... by 21.6% year-over-year to RMB82.7 million from RMB68.0 ...
... Uroplasty, Inc. (NASDAQ: UPI ), a medical ... products for the treatment of patients with voiding dysfunctions, ... expand its commitment to using the Company,s neuromodulation technology ... begin development of an implantable tibial nerve stimulator for ...
Cached Medicine Technology:China Kanghui Holdings Reports First Quarter 2012 Financial Results 2China Kanghui Holdings Reports First Quarter 2012 Financial Results 3China Kanghui Holdings Reports First Quarter 2012 Financial Results 4China Kanghui Holdings Reports First Quarter 2012 Financial Results 5China Kanghui Holdings Reports First Quarter 2012 Financial Results 6China Kanghui Holdings Reports First Quarter 2012 Financial Results 7China Kanghui Holdings Reports First Quarter 2012 Financial Results 8China Kanghui Holdings Reports First Quarter 2012 Financial Results 9China Kanghui Holdings Reports First Quarter 2012 Financial Results 10China Kanghui Holdings Reports First Quarter 2012 Financial Results 11China Kanghui Holdings Reports First Quarter 2012 Financial Results 12China Kanghui Holdings Reports First Quarter 2012 Financial Results 13Uroplasty Announces Product Development and New Clinical Trial Initiatives 2Uroplasty Announces Product Development and New Clinical Trial Initiatives 3Uroplasty Announces Product Development and New Clinical Trial Initiatives 4
(Date:10/22/2014)... Best Cheap Hosting USA is among the ... has recently announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is ... around the world. , “iPower is one of the ... providing various kinds of useful products for new and ... excellent customer service and a number of features which ...
(Date:10/22/2014)... Although there are only 24 hours in a day, that doesn’t ... finding time within their busy schedules for exercise and fitness. Fortunately, ... to get in shape. Here are five ways you can reach ... Change Up Your Commute , Consider riding a bike or taking ... your daily routine. If you must use your car to get ...
(Date:10/22/2014)... WALTHAM, MA (PRWEB) October 22, 2014 ... developing new solutions for the treatment of bacterial infections, ... J. Sinskey has joined its board of directors. ... Microbiology and Engineering Systems at The Massachusetts Institute of ... the MIT faculty since 1968. Dr. Sinskey also holds ...
(Date:10/22/2014)... -- Two sisters in high school have developed ways ... Medha Krishen use electronic stethoscopes, which electronically amplify body ... patterns or heartbeats. Ilina, a senior at Port ... a way to detect early lung damage in people ... Ilina recorded one breath cycle each from 16 smokers, ...
(Date:10/22/2014)... Oct. 21, 2014 (HealthDay News) -- Measures taken by ... in Ebola-ravaged Liberia may have limited the spread of ... report. The Firestone Natural Rubber Co. provides health ... residents of nearby densely populated communities. Between Aug. ... suspected Ebola cases among those 80,000 people. That incidence ...
Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
... ... has joined the Climate Savers Computing Initiative, a non-profit organization dedicated to reducing computer power ... ... that it has joined the Climate Savers Computing Initiative, a non-profit organization dedicated to reducing ...
... ... few short months ago the Pionetics Corporation introduced the LINX® Water Treatment System, the smartest ... so well, the company just shipped its 1,000th unit., , ... San Carlos, CA (PRWEB) June 25, 2010 -- Just a ...
... red wine, grapes, blueberries, peanuts and other plants ... to vision researchers at Washington University School of Medicine ... preserving vision in blinding eye diseases such as diabetic ... blindness in Americans over 50. The formation of ...
... ... Bob Adams speaks out for drug awareness and education. , , ... Los Angeles (Vocus) June 26, 2010 -- Addressing a ... Church of Scientology Community Relations Specialist, Bob Adams asked the youth who among them ...
... , ... announce that Asia Research News 2010 is now available online and in print. , ... (PRWebUK) June 24, 2010 -- We ... online at Asia Research News , , , , ,The magazine features interesting on-going ...
... experienced the strong heartbeat that accompanies emotions such as fear ... emotions be used to combat heart failure? Results of a ... present a strong case. In the ... that two experimental drugs have the potential to restore pumping ...
Cached Medicine News:Health News:Be Green Canada Joins Computing Initiative 2Health News:Be Green Canada Joins Computing Initiative 3Health News:Pionetics Ships its 1,000th LINX Drinking Water System 2Health News:Pionetics Ships its 1,000th LINX Drinking Water System 3Health News:Ingredient in red wine may prevent some blinding diseases 2Health News:Ingredient in red wine may prevent some blinding diseases 3Health News:Young Athletes Warned of Drug Dangers 2Health News:Young Athletes Warned of Drug Dangers 3Health News:Asia Research News 2010 2Health News:Asia Research News 2010 3Health News:Targeting flight-or-fight hormone response to combat heart failure 2Health News:Targeting flight-or-fight hormone response to combat heart failure 3